1 / 17

T Arbuckle, F McNeill, M Inskip , D Chettle, WI Manton, M Fisher, N Healey, R Bray, L. Marro

All ages study of blood-lead and bone-lead in urban Toronto: lessons learned from a collaborative study. T Arbuckle, F McNeill, M Inskip , D Chettle, WI Manton, M Fisher, N Healey, R Bray, L. Marro

nodin
Download Presentation

T Arbuckle, F McNeill, M Inskip , D Chettle, WI Manton, M Fisher, N Healey, R Bray, L. Marro

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. All ages study of blood-lead and bone-lead in urban Toronto: lessons learned from a collaborative study T Arbuckle, F McNeill, M Inskip, D Chettle, WI Manton, M Fisher, N Healey, R Bray, L. Marro Main funding: Health Canada, [Chemicals Surveillance Bureau, Environmental and Radiation Health Sciences Directorate]

  2. Co-investigators and groups Health Canada Tye Arbuckle (Co -PI) Mandy Fisher Mike Inskip (now with McMaster University) Norm Healey (now with Azimuth Consulting Group) Leonora Marro Department of Health Physics, McMaster Univ David Chettle Fiona McNeill (Co-PI) SepidehBehinaein (Ph.D student) University of Texas at Dallas William Manton Hospital coordinating centre– St Joseph’s Hospital, Toronto Jessica Tyrwhitt Toronto Public Health Riina Bray

  3. Talk outline • Goals, study design and context • Techniques used • Results so far ….. • Lessons learned • Discussion / summary

  4. Study goals The first Canadian study that we are aware of which attempts to measure bone Pb in young children. The pilot study goals were to demonstrate: • the feasibility of including in vivo XRF measurements of Pb in bone for young children in future surveys [like the ‘Canadian Health Measures Survey’] • the feasibility of 1) remote bone Pb measurements; • 2) partnership with a local community health centre for recruitment and subject measurement; • 3) quantification of serum Pb concentrations in environmentally exposed subjects • 4) recruitment of childhood subjects for venous blood sampling; • 5) development and delivery of appropriate risk communication materials.

  5. Testing and recruitment successTOTAL: 263/272 Participants Age ExpectedTested Males FemalesMales Females 1 to 5 10 10 10 6 6 to 10 23 20 23 16 11 to 19 23 20 23 20 20 to 35 21 25 21 25 36 to 50 25 29 25 29 51 to 64 21 24 21 24 65 to 85 10 11 9 11 Total 133 139132 131 • 1 participant cancelled; 2 participants did not assent to participate in the study; • 5 appointments were cancelled - equipment malfunction (participants rescheduled)

  6. Methods / techniques for success:plans and reality #1 • Very effective (and persistent) hospital coordinator for reaching potential volunteers / scheduling visits • Patient-friendly & very skilled child phlebotomist and measuring staff and well-designed procedures for family groups being measured + questionnaire time allowed. • Financial ($50) incentive • YES • YES – but early-on suspected a brief contamination event; Used TV games and books & adult distractions to keep children engaged • YES – but poorer participation rate by younggirls vs the boys

  7. Methods / techniques for success:plans and reality # 2 • Training for obtaining serum samples (Class-100 clean room, gloves etc., centrifuge on site) and pre-cleaned sample tubes, sample dispatch processes. • Choice of experienced analytical lab for Pb • Communications with volunteers about health risk by Toronto Public Health personnel very familiar with PbB exposure routes in homes. • YES – but Couriers lost one batch of samples • YES: …although challenges. • Low blood lead values did not necessitate many home visits.

  8. 1st blood sample - venipuncture for:whole blood and hematocrit Bluetop Vacutainer tube Place a drop of blood sample onto slide and draw into a capillary tube.  The capillary tube is then spun to separate the red blood cells from the plasma at which time a Hematocrit value can then be measured. 

  9. 2nd sample : Venipuncture for:blood serum sample to measure a person’s Hematocrit is by • Use butterfly +syringe to slowly collect • 5ml blood. Remove butterfly tip, leave sample stand 20 minutes. • NB The following are done in CLEAN BOX • Slowly transfer blood to centrifuge tube* • Spin down using bench centrifuge • Decant plasma (Special tip*) into Teflon jar* • Record patient I.D. against jar number • Tighten lid & freeze sample • * provided

  10. Why is use of a HEPA Clean Box (Class-100 air) important? • Differences: at least 100 times (!) less Pb is present in Plasma vs. whole blood • E.g., If PbB = 1 ug/dL, plasma Pb = 0.01 ug/dL or 100 pg/ml • Where things can get contaminated • Pb on airborne particles • Pb on hands or any surfaces. • One speck of dust enough to contaminate sample • Pb can also leach-out from plastics

  11. Blood collection protocol • Blood volume: the phlebotomist must do their best to obtain as much as possible - up to the desired amount of 5mL. • For the serum sample, the tube is left to stand for 20 minutes • After centrifuging, a dedicated pipeter is used to transfer plasma; when not in use, it is kept in the clean box as the photo shows (hanging). • The rack of pre-cleaned 15 mL teflon jars and the centrifuge tubes must never leave the clean box. • The transfer of the supernatant plasma to the tubes must be done in the box.

  12. Treatment of sample when taken

  13. Benchtop centrifuges for plasma / hematocrit

  14. Results: Blood lead vs age (*male / *female)

  15. Systematic representation of vascular organisation in the diaphysis of a long-bone (From Mayo Foundation for Medical Education and Research)

  16. Summary • Blood lead levels were lower than expected …but in the range found for the CHMS survey; Lead levels in serum required special attention for analysis • Serum lead levels were so low that the Texas laboratory had to develop a new technique to measure them. • Special attention to training of collection staff was a good investment (and critically important for obtaining reliable data). • Bone lead data were successfully obtained for young children by in vivo XRF; Themethod is being further evaluated as a tool for measuring children’s skeletal burden. • A multi-disciplinary team approach was considered essential for this study.

  17. Summary (2) • Analysis of data continues: e.g.: • Bone/PbB/serum data • Questionnaire results related to values • Additional information on isotope ratios in blood samples & possible source of environmental Pb

More Related